IBD News

February 16, 2016February 16, 2016

Ulcerative Colitis Patients Resistant to Treatment May Find Golimumab a Viable Therapeutic Option

Golimumab (symponi) is the latest addition to TNF-α blocking drugs for inflammatory bowel diseases (IBD) such as ulcerative colitis (UC). A summary of all available safety and efficacy data on the ... Read more

February 15, 2016February 15, 2016

Treatment of IBD Moves Forward with Partnership Between Synlogic and AbbVie to Develop New Class of Medicines

Crohn's Disease, IBD News, News, Ulcerative colitis

Synlogic recently announced the establishment of a global Research and Development collaboration with AbbVie to develop innovative medicines for the treatment of inflammatory bowel disease (IBD), taking advantage of Synlogic’s proprietary ... Read more

February 12, 2016February 12, 2016

First Biosimilar Therapy for Crohn’s Disease and Ulcerative Colitis Is Focus of FDA Meeting

Crohn's Disease, IBD News, News, Ulcerative colitis

The U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee recently met to review a biologics license application (BLA) submitted by Celltrion Inc. for its compound CT-P13, a proposed biosimilar to Remicade ... Read more

February 11, 2016February 12, 2016

RedHill Biopharma’s Potential Crohn’s Treatment, RHB-104, Likely to Receive US Patent

Crohn's Disease, IBD News, News

RedHill Biopharma recently announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent covering RHB-104, a new oral combination drug currently being assessed in clinical ... Read more

February 10, 2016February 10, 2016

Ulcerative Colitis Disease Activity: Rectosigmoidoscopy Strongly Correlates With Colonoscopy Results

IBD News, News, Ulcerative colitis

In a new study, researchers compared the efficacy of two techniques, rectosigmoidoscopy and colonoscopy, for the measurement of endoscopic healing in patients with ulcerative colitis, and found a strong correlation ... Read more

February 5, 2016February 5, 2016

Drug for Ulcerative Colitis Is Focus of OASIS Clinical Trial

IBD News, News, Ulcerative colitis

A new study being conducted in more than 100 clinical centers across the world is evaluating the safety and efficacy of a new investigational drug for the treatment of mild ... Read more

February 2, 2016September 26, 2016

Dietary Management of Ulcerative Colitis, Gastroenterological Conditions Aided With New Probiotic

IBD News, News, Ulcerative colitis

ExeGi Pharma, based in Gaithersburg, Maryland, recently announced the launch of Visbiome and Visbiome Extra Strength, the company’s new probiotic formulations for the dietary management of gastroenterological conditions such as ulcerative colitis, ... Read more

February 1, 2016February 1, 2016

Advanced Dermatology Partners With Crohn’s & Colitis Foundation for Take Steps Program

Crohn's Disease, IBD News, News

Advanced Dermatology is collaborating with the Crohn’s & Colitis Foundation of America to raise funds and assist CCFA’s Take Steps walk program to support critical research and patient support for the 1.6 million Americans living ... Read more

January 7, 2016January 8, 2016

Depression Symptoms in Pediatric IBD Can Be Predicted by Inflammatory Markers and Disease Activity

IBD News, News

Results from a study recently presented at the 2015 Advances in IBD Meeting showed that inflammatory markers and disease activity were predictors of anhedonia and somatic-affective symptoms in pediatric patients ... Read more

December 19, 2015December 21, 2015

Study Reports that Pregnant Women With Inflammatory Bowel Disease Often Have Nutritional Deficiencies

IBD News, News

New data from researchers at the University of Wisconsin, Madison recently revealed that pregnant women with inflammatory bowel disease (IBD) are more prone to developing deficiencies in nutritional parameters. The ... Read more